美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
HYTRIN	019057	001	NDA	TERAZOSIN HYDROCHLORIDE	TABLET;ORAL	EQ 1MG BASE	No	No	1987/08/07	1987/08/07	ABBOTT	Discontinued
HYTRIN	019057	002	NDA	TERAZOSIN HYDROCHLORIDE	TABLET;ORAL	EQ 2MG BASE	No	No	1987/08/07	1987/08/07	ABBOTT	Discontinued
HYTRIN	019057	003	NDA	TERAZOSIN HYDROCHLORIDE	TABLET;ORAL	EQ 5MG BASE	No	No	1987/08/07	1987/08/07	ABBOTT	Discontinued
HYTRIN	019057	004	NDA	TERAZOSIN HYDROCHLORIDE	TABLET;ORAL	EQ 10MG BASE	No	No	1987/08/07	1987/08/07	ABBOTT	Discontinued
HYTRIN	020347	001	NDA	TERAZOSIN HYDROCHLORIDE	CAPSULE;ORAL	EQ 1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/12/14	1994/12/14	ABBOTT	Discontinued
HYTRIN	020347	002	NDA	TERAZOSIN HYDROCHLORIDE	CAPSULE;ORAL	EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/12/14	1994/12/14	ABBOTT	Discontinued
HYTRIN	020347	003	NDA	TERAZOSIN HYDROCHLORIDE	CAPSULE;ORAL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/12/14	1994/12/14	ABBOTT	Discontinued
HYTRIN	020347	004	NDA	TERAZOSIN HYDROCHLORIDE	CAPSULE;ORAL	EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/12/14	1994/12/14	ABBOTT	Discontinued